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ABSTRACT 
1,3,4-oxadiazole is a five member heterocyclic ring which is a very important compound for designing potent bioactive agents. This interesting 
group of compound has different biological activities such as anti-inflammatory, antimicrobial, anticancer, antitubercular, anticonvulsant, anti-
HIV, hypogycemic and antioxidant etc. In the present research work, we have synthesized four newly 1,3,4-oxadiazole derive atives derived from 
existing NSAID Ibuprofen. The purity of compounds was checked by TLC and melting point. The melting point was determined by open capillary 
methods and uncorrected. Structure of all four newly synthesized compounds was confirmed by spectral analysis (FTIR, and 1HNMR). 
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INTRODUCTION 
Oxadiazole are widely used in pharmaceutical research to 
develop active drug substances. Among the all hetrocyclics, 
1,3,4-oxadiazole is the very important class in synthetic 
medicinal chemistry having different biological activities  
such as anti-inflammatory1, analgesic2, antimicrobial3, anti-
HIV4, anticancer5, anthelmintic6, anticonvulsant7, antiviral8, 
hypoglycemic9, antitubercular10. Now we have synthesized 
some new 1,3,4-oxadiazole derivatives derived from 
Ibuprofen and characterized with spectral analysis.  
MATERIAL AND METHODS 
Synthetic studies 
The title compounds were synthesized as given in the 
scheme 1. Ibuprofen was refluxed with absolute ethanol in 
presence of conc. Sulphuric acid to gave ester of Ibuprofen 
(I), this on reaction with hydrazine hydrate (99%) in 
absolute ethanol gave carbohydrazide of ibuprofen (II), this 
compound was refluxed with CS2 in ethanol in the presence 
of KOH gave 1,3,4 - oxadiazole attached with Ibuprofen (III). 
The title compounds (IVa-d) were synthesized by reaction of 
III with various amines in presence of formaldehyde. 
Spectral studies 
The purity of compounds was checked by TLC and melting 
point. The melting point was determined by open capillary 
methods and uncorrected. Structure of all four newly 
synthesized compounds was confirmed by spectral analysis 
(FTIR, and 1HNMR). The IR and 1H-NMR spectral data are 
given in the result and discussion part.  
RESULT AND DISCUSSION 
The sequence of the reaction employed for the synthesis of 
title compounds is outlined in Scheme 1. The 
physicochemical data and spectral data of the different 
synthesized compounds are given in Table I and Table II. 
The Ibuprofen was converted to its ethyl esters (I) by 
esterification. The purity of the compound was confirmed by 
melting point, TLC and structure was confirmed by chemical 
test, IR and 1HNMR spectral data. IR spectra showed the 
characteristic peak C-H stretching at 3082 cm-1, C=O at 1730 
cm-1, C-O-C at 1238 cm-1, C-Cl at 783 cm-1. This was further 
supported by 1H-NMR spectral data given in table II. This 
methyl ester was reacted with hydrazine hydrate, gave 
carbohydrazide (II). The purity of this compound was 
confirmed by melting point, TLC and structure was 
confirmed by IR and 1HNMR spectral data. IR spectra showed 
the characterstic peak C-H stretching at 3022 cm-1, C=O at 
1637 cm-1, C-Cl at 770 cm-1. This was further supported by 
1H-NMR spectral data with δ value given in table II. This 
carbohydrazide was treated with CS2/ KOH in ethanol gave 
1,3,4- oxadiazole ring attached with Ibuprofen (III). The 
purity of the compound was confirmed by melting point, TLC 
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and structure was confirmed by IR and 1HNMR spectral data. 
IR spectra showed the characterstic peak of C-H stretching at 
3086 cm-1, C=N at 1503 cm-1, C=S at 1162 cm-1, C-Cl at 777 
cm-1. This was further supported by 1HNMR spectral data 
with δ value given in table II. Treatment of III with various 
amines in presence of formaldehyde gave the title 
compounds IVa-d. The purity of these compounds were 
assessed by melting point, TLC and Structure were 
confirmed by IR, and 1HNMR data. Physicochemical data and 
spectral data of the different synthesized title compounds 
(IVa-d) are given in Table I and Table II. 
CONCLUSION 
The four derivative of 1,3,4-oxadiazole were derived from 
Ibuprofen by different chemical reaction. All the synthesized 
compounds were characterized by physiochemical, 
chromatographically and spectral analysis. The melting point 
and thin-layer chromatography (TLC) were performed for 
check purity of the synthesized compounds. Spectral studies 
i.e. FTIR and 1HNMR were performed for structure 
confirmation. All four compounds were synthesized with 
good yield. 
 
Scheme 1 
Table I:  Physico-chemical data of title compounds  (IVa-d) 
Compound R R M.P. (°C) Yield (%) Rf * 
IVa  Morpholine 
 
132-134 74.5 0.30 
IVb  Diethyl amine 216-218 69.9 0.41 
IVc  Piperidine 
 
102-104 70.7 0.29 
IVd  2-Methyl Piperidine 184-186 70.7 0.44 
 
All compounds were recrystallized by methanol. 
Stationary phase*- silica gel G. 
Mobile phase- ethyl acetate: chloroform (4:1). 
Visualizing agent- iodine vapours. 
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Table II: Spectral data of title compounds (IV a-d) 
Compound R IR spectra (KBr cm-1) 
1H NMR spectra  
(CDCl3,δ, ppm) 
 
 
IV a 
 
3068(C-H), 1576(C=N), 
1511(C=C), 1312(C=S), 
1249(C-O-C). 
7.36-7.55(m, 4H, Ar-H), 3.05(s,1H, C-H), 1.93(s, 3H,CH3), 
4.17(s, 2H, CH2), 2.12 (s, 2H, CH2), 1.92 (s,1H, CH), 1.12 (t, 
6H, CH3, CH3 of Ibuprofen), 3.68-3.65(t, 4H,morpholine), 
2.79-2.76(t, 4H, morpholine). 
 
 
IV b 
 2967(C-H), 1575(C=N), 
1501(C=C), 1322(C=S), 
1276(C-O-C). 
 
7.66-7.85(m, 4H, Ar-H), 3.15(s,1H, C-H), 1.98(s, 3H,CH3), 
4.55(s, 2H, CH2), 2.22 (s, 2H, CH2), 1.97 (s,1H, CH), 1.22 (t, 
6H, CH3, CH3 of Ibuprofen) , 3.02-2.60(m, 4H, CH2, CH2), 
1.33-1.30(t, 6H, CH3, CH3). 
IV c 
 
2926(C-H), 1575(C=N), 
1505(C=C), 1352(C=S), 
1245(C-O-C). 
7.76-7.45(m, 4H, Ar-H), 2.95(s,1H, C-H), 1.98(s, 3H,CH3), 
4.25(s, 2H, CH2), 2.22 (s, 2H, CH2), 1.96 (s,1H, CH), 1.12 (t, 
6H, CH3, CH3 of Ibuprofen), 2.80-2.72(t, 4H, piperidine), 
1.64(m, 2H, piperidine), 1.51-1.24(m, 4H,piperidine). 
 
 
IV d 
 
2942(C-H), 1578(C=N), 
1507(C=C), 1299(C=S), 
1237(C-O-C). 
 
7.15-7.52(m, 4H, Ar-H), 3.25(s,1H, C-H), 1.96(s, 3H,CH3), 
4.25(s, 2H, CH2), 2.18 (s, 2H, CH2), 1.98 (s,1H, CH), 1.17 (t, 
6H, CH3, CH3 of Ibuprofen), 2.80-2.72(m, 1H, piperidine), 
1.74-1.55(m, 6H, piperidine), 1.37-1.35(d, 3H, 2-methyl 
piperidine), 1.25(m, 2H, piperidine). 
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